Paratus Sciences Funding: $100M Raised, Series A (2023)
Paratus Sciences is based in New York, NY. It has raised $100M in total funding. Latest round: Series A.
Paratus Sciences funding overview
Paratus Sciences is based in New York, NY. Paratus Sciences has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Paratus Sciences runs through 2023; nothing later has been disclosed. Investors on record include Polaris Partners, ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Alexandria Venture Investments. 6 distinct backers are named across the disclosed rounds.
Paratus Sciences has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Paratus Sciences?
Polaris Partners, ARCH Venture Partners, ClavystBio, EcoR1 Capital, Leaps by Bayer, Alexandria Venture Investments are named among the investors backing Paratus Sciences.
What was the latest Paratus Sciences funding round?
The most recent disclosed round is a Series A, announced in March 2023.
Where is Paratus Sciences based?
Paratus Sciences is based in New York, NY.
When did Paratus Sciences last raise?
The last disclosed Paratus Sciences round closed in March 2023 at Series A.
Paratus Sciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in New York below to benchmark round size and investor mix.
